Jiangsu Backs Pharma Overseas M and A
Chinese biotech hub Jiangsu province has pledged support for local pharmaceutical companies pursuing international acquisitions and licensing agreements. The initiative aims to boost global trade participation as drugmakers seek foreign partnerships.
Xurve View
Insights:
Xurve View
China's Jiangsu province pledged support on Wednesday for pharmaceutical companies pursuing foreign acquisitions, licensing agreements, and joint development projects. The provincial initiative arrives as Beijing tightens regulatory scrutiny over sensitive technologies and cross-border commercial transactions.
